UK consults on GSL move for naproxen

18 February 2014 - Deborah Wilkes


Galpharm Healthcare is seeking to switch 250mg naproxen tablets for period pain from pharmacy to general-sales-list (P-to-GSL) status in the UK.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: